ArticleCommunications medicine2025
A national cross-sectional study of the role of clinician specialty and facility complexity on glucocorticoid prescribing in Veterans.
Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundGlucocorticoids are used commonly despite their toxicity and availability of effective alternatives. Prior claims-based studies evaluating effect of clinician specialty on glucocorticoid prescribing do not examine how facility-level resources affect prescribing patterns. We aim to describe the effect of facility complexity and clinician specialty on oral glucocorticoid prescribing in the general population.
methodsThis is a national cross-sectional study of Veterans prescribed oral glucocorticoids during 2021-2022. We defined glucocorticoid use as ≥1 outpatient pharmacy claim for oral glucocorticoids, and prolonged use as ≥30 days' supply dispensed within 365 days. We defined complexity, rurality, and region using VHA operational metrics, and clinician specialty using NUCC taxonomy codes. We descriptively evaluated demographics, comorbidities, and healthcare utilization stratified by glucocorticoid use. We calculated the proportion of users and prolonged users at each facility, stratified by complexity, rurality, and region. We calculated the proportion of glucocorticoid prescriptions by clinician specialty. For three high-prescribing specialties, we calculated the facility-level proportion of glucocorticoid prescriptions by complexity designation.
resultsHere we show that among 5,729,134 patients at 124 facilities, a mean of 12.1% (SD 3.5%) are glucocorticoid users; 2.1% (SD 0.5%) were prolonged users. Rates of use and prescribing vary substantially within and across facility complexity designations. Family practice represents 18.8% of glucocorticoid-prescribing clinicians but prescribes 26.3% of filled prescriptions. Family practice displays higher prescribing at lower-complexity sites.
conclusionsIn this large national population, overall and prolonged glucocorticoid use are common and prescribing patterns vary by clinician type and complexity designation. Clinician-facing interventions to address knowledge gaps, incentivize non-glucocorticoid treatments, or facilitate specialty care access may reduce overuse among high-prescribing clinicians.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.